Fixed dilated pupils and tacrolimus toxicity in paediatric liver transplant patients

Claire Westrope1, Helen Rowlands, Kevin Morris

  • 1Paediatric Intensive Care Unit, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK. claire@westropes.co.uk

Pediatric Transplantation
|February 18, 2010
PubMed

Insights

High tacrolimus levels in children after liver transplants can cause fixed dilated pupils. This post-operative complication is linked to drug concentrations exceeding 30 ng/mL.

Area of Science:

  • Pediatric Surgery
  • Pharmacology
  • Ophthalmology

Background:

  • Tacrolimus is an immunosuppressant crucial for preventing organ rejection in pediatric transplant recipients.
  • Monitoring tacrolimus levels is essential to balance efficacy and toxicity, especially in pediatric patients.

Observation:

  • A case series identified four pediatric patients presenting with fixed dilated pupils post-liver or liver-small bowel transplantation.
  • This neurological sign correlated with elevated serum tacrolimus concentrations, surpassing 30 nanograms/millilitre.

Findings:

  • Fixed dilated pupils represent a potential, albeit rare, clinical manifestation of tacrolimus toxicity in pediatric transplant patients.
  • The observed association highlights the importance of vigilant neurological monitoring in the immediate post-operative phase.

Implications:

  • Early recognition of fixed dilated pupils may prompt timely tacrolimus level assessment and dose adjustment.
  • This finding contributes to a better understanding of the neuro-ophthalmic side effects of tacrolimus in pediatric transplantation.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...